HPBT
SNDX icon

Hickory Point Bank & Trust’s Syndax Pharmaceuticals SNDX Stock Holding History

Hickory Point Bank & Trust’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4K Hold
750
– – 0.01% 319
2026
Q1 		$17.5K Buy
+750
New +$16.3K 0.01% 305

Other funds holding SNDX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
VIG
Vienna Insurance Group Warsaw, Poland $381M AUM 105.39% 1-Year Est. Return
TIP
Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Hickory Point Bank & Trust's SNDX Position: Q2 2026 in Review

Hickory Point Bank & Trust held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 750 shares worth $16.4K. The position accounts for 0.01% of the portfolio, ranked #319.

Hickory Point Bank & Trust first reported a position in SNDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $17.5K in Q1 2026. 36 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Hickory Point Bank & Trust held 750 shares of Syndax Pharmaceuticals worth $16.4K as of Q2 2026.
  • Hickory Point Bank & Trust left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
  • Syndax Pharmaceuticals made up 0.01% of Hickory Point Bank & Trust's portfolio in Q2 2026, its #319 holding.
  • Hickory Point Bank & Trust first reported a position in Syndax Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Hickory Point Bank & Trust's Syndax Pharmaceuticals position peaked at $17.5K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Hickory Point Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.